The body produces its own glutathione (GSH) but it is depleted by poor diet, pollution, toxins, medications, stress, trauma, aging, infections, and radiation
Related BPC-157 Research Compounds Researchers working with the BPC-157 TB-500 blend may also be interested in these related compounds from our catalogue: BPC-157 5mg standalone BPC-157 for isolated single-compound research protocols BPC-157 10mg higher dosage standalone vial for extended research cycles BPC-157 15mg maximum standalone dosage for high-concentration laboratory studies BPC-157 + TB-500 20mg Blend double-strength version of this formulation for extended protocols BPC-157 + TB-500 + GHK-Cu 30mg Glow Blend triple-compound blend adding copper peptide for extracellular matrix research All compounds are independently tested by Janoshik Analytical and supplied with batch-specific COA documentation
(2012) characterized GHK-Cus broad gene expression effects, establishing the tissue remodeling component of this blend [2]
BPC-157 research reference: View study on PubMed TB-500 research reference: View study on PubMed Buy the BPC-157 + TB-500 Research Blend cGMP Manufactured in Dallas, TX LiveWell Peptides manufactures the BPC-157 / TB-500 research blend in our cGMP facility in Dallas, Texas
Abstract Background: Although oxidative stress is known to contribute to cancer, and endogenous and exogenous antioxidants are thought to prevent tumorigenesis by suppressing oxidative stress-induced DNA damage, antioxidants have also been reported to show negative effects on tumor formation, necessitating characterization of the causal associations between antioxidants and cancer risk